Allurion Technologies (NYSE:ALUR – Get Free Report) is set to issue its quarterly earnings data before the market opens on Wednesday, November 13th. Analysts expect the company to announce earnings of ($0.17) per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.
Allurion Technologies (NYSE:ALUR – Get Free Report) last issued its quarterly earnings results on Tuesday, August 13th. The company reported $0.01 EPS for the quarter. The business had revenue of $11.77 million for the quarter. On average, analysts expect Allurion Technologies to post $0 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Allurion Technologies Stock Performance
Shares of ALUR opened at $0.72 on Tuesday. The firm has a market capitalization of $46.58 million, a price-to-earnings ratio of -0.82 and a beta of -0.37. Allurion Technologies has a one year low of $0.55 and a one year high of $4.64. The stock’s fifty day moving average is $0.68 and its 200-day moving average is $1.07.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on Allurion Technologies
Allurion Technologies Company Profile
Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.
See Also
- Five stocks we like better than Allurion Technologies
- Consumer Discretionary Stocks Explained
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- Comparing and Trading High PE Ratio Stocks
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- What is the S&P/TSX Index?
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Allurion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allurion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.